MIAMI BEACH, FLA. — A minimally invasive treatment that quickly freezes and kills tumors provides pain relief to patients whose cancer has spread to the bone and soft tissue, suggests research being presented at the 6^th annual Symposium on Clinical Interventional Oncology (CIO), in collaboration with the International Symposium on Endovascular Therapy (ISET).

Cryoablation therapy is a simple, one-time treatment that destroys painful metastatic tumors, meaning cancer that has spread from the primary site in the breast, kidneys, skin and other areas. Standard treatments for pain relief in these patients include narcotic medications and radiation therapy, which often interfere with daily quality of life and may require interruption of chemotherapy treatments.

“Pain can take over the lives of cancer patients and relief of that pain through this simple one-day outpatient procedure can significantly improve time with loved ones,” said J. David Prologo, M.D., lead author of the study, and interventional radiologist at the Centers for Dialysis Care, Cleveland. “It’s very rewarding to see how cryoablation can positively and dramatically impact lives.”

Read more from this article published in the Fort Mill Times here

Dr Rowland Illing has just taken part in an invited debate to a large audience of international experts on the treatment of small renal tumours in the older patient. He discussed the latest evidence supporting the role of minimally invasive treatments, in particular cryoablation and radiofrequency ablation. Views on the roles of active surveillance and minimally invasive surgery were provided by Dr Volpe and Prof Janetschek.

The scientific programme can be found here.

https://www.healthinsurancedaily.com/health-insurance/product-area/life-critical-illness/article430979.ece

Nearly a third of a million people are being diagnosed with cancer each year in the UK, according to the charity Cancer Research UK.

Read more